Submitted:
27 September 2024
Posted:
29 September 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results


4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Nathavitharana RR, Lederer P, Tierney DB, Nardell E, Barry CE, Behr MA, et al. The global burden of latent tuberculosis infection: A systematic review and meta-analysis. Lancet Infect Dis. 2021;21(12):1648-58. [CrossRef]
- Selvavinayagam ST, Aswathy B, Yong YK, Frederick A, Murali L, Kalaivani V, et al. Plasma CXCL8 and MCP-1 as surrogate plasma biomarkers of latent tuberculosis infection among household contacts – A cross-sectional study. PLOS Glob Public Health. 2023;3(11). [CrossRef]
- Chee CB, Reves R, Zhang Y, Belknap R. Latent tuberculosis infection: Opportunities and challenges. Respirology. 2018;23(10):893-900. [CrossRef]
- Price C, Nguyen AD. Latent tuberculosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan 11. Available from: https://www.ncbi.nlm.nih.gov/books/NBK599527/ (accessed on 2024 Sep 23).
- Cadena AM, Fortune SM, Flynn JL. Heterogeneity in tuberculosis. Nat Rev Immunol. 2017;17(11):691-702. [CrossRef]
- Glaziou P, Floyd K, Raviglione MC. Global epidemiology of tuberculosis. Semin Respir Crit Care Med. 2018;39(03):271-85. [CrossRef]
- Daley CL. The global fight against tuberculosis. Thorac Surg Clin. 2019;29(1):19-25. [CrossRef]
- Matteelli A, Sulis G, Capone S, D’Ambrosio L, Migliori GB, Getahun H. Tuberculosis elimination and the challenge of latent tuberculosis. Presse Med. 2017;46(2). [CrossRef]
- Rojano B, Caminero JA, Hayek M. Curving tuberculosis: Current trends and future needs. Ann Glob Health. 2019;85(1). [CrossRef]
- Trajman A, Wakoff-Pereira MF, Ramos-Silva J, Cordeiro-Santos M, Militão de Albuquerque M, Hill PC, et al. Knowledge, attitudes and practices on tuberculosis transmission and prevention among auxiliary healthcare professionals in three Brazilian high-burden cities: A cross-sectional survey. BMC Health Serv Res. 2019;19(1):1-8. [CrossRef]
- Tang P, Liang E, Zhang X, Feng Y, Song H, Xu J, et al. Prevalence and risk factors of subclinical tuberculosis in a low-incidence setting in China. Front Microbiol. 2022;12:731532. [CrossRef]
- World Health Organization. Latent tuberculosis Infection - Executive Summary. Geneva: WHO; 2018.
- Loutet M, Burman M, Jayasekera N, Trathen D, Dart S, Kunst H, et al. National roll-out of latent tuberculosis testing and treatment for new migrants in England: A retrospective evaluation in a high-incidence area. Eur Respir J. 2018;51(1):1701226. [CrossRef]
- Coppeta L, Pietroiusti A, Neri A, Janni A, Baldi S, Papa F, et al. Prevalence and risk factors for latent tuberculosis infection among healthcare workers in a low incidence country. Open Respir Med J. 2019;13(1):1-4. [CrossRef]
- Chen C, Zhu T, Wang Z, Peng H, Kong W, Zhou Y, et al. High latent TB infection rate and associated risk factors in the eastern China of low TB incidence. PLoS One. 2015;10(10). [CrossRef]
- Apriani L, McAllister S, Sharples K, Alisjahbana B, Ruslami R, Hill PC, et al. Latent tuberculosis infection in healthcare workers in low- and middle-income countries: An updated systematic review. Eur Respir J. 2019;53(4):1801789. [CrossRef]
- Grobler L, Mehtar S, Dheda K, Adams S, Babatunde S, Walt Mvd, et al. The epidemiology of tuberculosis in health care workers in South Africa: A systematic review. BMC Health Serv Res. 2016;16(1). [CrossRef]
- Zhang X, Jia H, Liu F, Pan L, Xing A, Gu S, et al. Prevalence and risk factors for latent tuberculosis infection among health care workers in China: A cross-sectional study. PLoS One. 2013;8(6). [CrossRef]
- Birku M, Desalegn G, Kassa G, Tsegaye A, Abebe M. Effect of pregnancy and HIV infection on detection of latent TB infection by Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube assay among women living in a high TB and HIV burden setting. Int J Infect Dis. 2020;101:235-42. [CrossRef]
- LaCourse SM, Cranmer LM, Matemo D, Kinuthia J, Richardson BA, Horne DJ, et al. Effect of pregnancy on interferon gamma release assay and tuberculin skin test detection of latent TB infection among HIV-infected women in a high burden setting. J Acquir Immune Defic Syndr. 2017;75(1):128-36. [CrossRef]
- World Health Organization. Global report on Tuberculosis. Geneva, Switzerland: WHO; 2021.
- Bustamante-Rengifo JA, González-Salazar LA, Osorio-Certuche N, Bejarano-Lozano Y, Cuevas JRT, Astudillo-Hernández M, et al. Prevalence of and risk factors associated with latent tuberculosis infection in a Latin American region. PeerJ. 2020;8. [CrossRef]
- Gao J, Berry NS, Taylor D, Venners SA, Cook V, Mayhew M. Knowledge and perceptions of latent tuberculosis infection among Chinese immigrants in a Canadian urban centre. Int J Family Med. 2015;2015:1-10. [CrossRef]
- Gonzalez A, et al. Lifetime exposure to tuberculosis and risk of latent tuberculosis infection in older adults. J Infect Dis. 2018;218(4):640-8.
- Khan A, Rebhan A, Seminara D, Szerszen A. Enduring challenge of latent tuberculosis in older nursing home residents: A brief review. J Clin Med Res. 2019;11(6):385-90. [CrossRef] [PubMed]
- Menzies D, et al. The epidemiology of latent tuberculosis infection in HIV-positive individuals. Int J Tuberc Lung Dis. 2016;20(5):603-10. [CrossRef]
- Barker LF, et al. The impact of aging on the immune response to Mycobacterium tuberculosis. Clin Infect Dis. 2020;70(3):456-62.
- Kumar A, et al. Comorbidities and their impact on tuberculosis infection in older adults. BMC Infect Dis. 2021;21(1):123.
- Pawlowski A, et al. Tuberculosis and latent tuberculosis infection: A review and update. Am J Respir Crit Care Med. 2016;194(1):1-11. [CrossRef]
- World Health Organization. Global Tuberculosis Report 2022. Geneva: WHO; 2022. https://www.who.int/publications/i/item/9789240062000.
- Proença R, Souza FM, Bastos ML, Caetano R, Braga JU, Faerstein E, et al. Active and latent tuberculosis among refugees and asylum seekers: a systematic review and meta-analysis. 2019. [CrossRef]
- Pettipher CA, Benitha R. Tuberculosis in biologic users for rheumatic diseases: results from the South African Biologics Registry (SABIO). Ann Rheum Dis. 2019;79(2):292-9. [CrossRef]
- LoBue P, Mermin J. Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA. Lancet Infect Dis. 2017;17(10). [CrossRef]
- Eiset AH, Wejse C. Review of infectious diseases in refugees and asylum seekers—current status and going forward. Public Health Rev. 2017;38(1). [CrossRef]
- Belo C, Naidoo S. Prevalence and risk factors for latent tuberculosis infection among healthcare workers in Nampula Central Hospital, Mozambique. BMC Infect Dis. 2017;17(1). [CrossRef]
- Rai R, El-ZAemey S, Dorji N, Doj B, Fritschi L. Exposure to occupational hazards among health care workers in low- and middle-income countries: a scoping review. Int J Environ Res Public Health. 2021;18(5):2603. [CrossRef]
- Lee S, Kim Y, Cho Y, Jeong Y, Kim H, Lee J, et al. Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea: a prospective cohort study. BMC Infect Dis. 2014;14(1). [CrossRef]
- Goswami ND, Gadkowski LB, Piedrahita C, Bissette D, Ahearn MA, Blain M, et al. Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study. BMC Public Health. 2012;12(1). [CrossRef]
- Hailu G, Etefa M, Begna F. Assessment of knowledge, attitudes, and practices (KAP): public health and economic burden of tuberculosis in Jarso district of West Wollega Zone, Oromia, western Ethiopia. Biomed Res Int. 2022;2022:1-13. [CrossRef]
- Spruijt I, Haile DT, Nagel IM, Robijn AL, Heuvelings CC, Goossens J, et al. Latent tuberculosis infection and diabetes mellitus: An epidemiological study in the Netherlands. Int J Infect Dis. 2020;92:68-74. [CrossRef]
- Hernandez-Garduno E, et al. Longitudinal health outcomes of individuals with latent tuberculosis infection and their relationship with HIV status. BMC Infect Dis. 2019;19(1):1-8. [CrossRef]
- Tilahun M, Shibabaw A, Kiflie A, Bewket G, Abate E, Gelaw B. Latent tuberculosis infection and associated risk factors among people living with HIV and apparently healthy blood donors at the University of Gondar Referral Hospital, northwest Ethiopia. BMC Res Notes. 2019;12(1). [CrossRef]







| Question code | Question |
|---|---|
| Q1 | Have you ever heard of latent tuberculosis infection (LTBI) before? |
| Q2 | Have you ever received health education on LTBI and TB? |
| Q3 | What do you understand by the term “latent tuberculosis infection”? |
| Q4 | How is LTBI different from active tuberculosis (TB)? |
| Q5 | What are the risk factors for developing LTBI? |
| Q6 | What are the possible consequences of having untreated LTBI? |
| Q7 | Can LTBI progress to active TB? |
| Q8 | What are the recommended treatments for LTBI? |
| Q9 | Are there any preventive measures individuals with LTBI should take to avoid developing active TB? |
| Q10 | Do you think LTBI is a significant public health concern? |
| Q11 | How concerned are you about the possibility of progressing from LTBI to active TB? |
| Q12 | Do you believe that LTBI treatment is necessary, even if you do not have symptoms? |
| Q13 | How do you perceive the importance of LTBI screening programs? |
| Q14 | What barriers do you think may prevent individuals from seeking LTBI testing or treatment? |
| Q15 | Have you ever been screened for LTBI? |
| Q16 | If you tested for LTBI, did you receive treatment? |
| Q17 | If you received treatment for LTBI, did you complete the entire course of medication? |
| Q18 | Have you ever been in close contact with someone diagnosed with active TB? |
| Q19 | If yes, did you seek medical evaluation or testing for LTBI? |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).